|
|
|
Volumn 24, Issue 4, 2010, Pages 352-358
|
|
Current management of nasal NK/T-cell lymphoma.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADULT;
ARTICLE;
HUMAN;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
NK T CELL LYMPHOMA;
NOSE TUMOR;
PATHOLOGY;
RADIATION DOSE;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
HUMANS;
LYMPHOMA, EXTRANODAL NK-T-CELL;
MIDDLE AGED;
NOSE NEOPLASMS;
RADIOTHERAPY DOSAGE;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 77953033040
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (31)
|
|
References (0)
|
